Samlyn Capital, LLC Ideaya Biosciences, Inc. Transaction History

Samlyn Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$16.38 - $26.0 $18,558 - $29,458	-1,133 Reduced 0.14%	791,266 $13 Million
Q4 2024 Feb 14, 2025	SELL	$24.79 - $31.98 $617,469 - $796,557	-24,908 Reduced 3.05%	792,399 $20.4 Million
Q3 2024 Nov 14, 2024	BUY	$30.37 - $43.05 $6.24 Million - $8.85 Million	205,487 Added 33.59%	817,307 $25.9 Million
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $4.49 Million - $5.68 Million	130,595 Added 27.14%	611,820 $21.5 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $16.5 Million - $22.7 Million	481,225 New	481,225 $21.1 Million

238

82.1M

509K

103K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.54B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.